About this episode

Stéphane Bancel discusses how mRNA technology is transforming healthcare and the shift from a one-size-fits-all model.

For more than a century, medicine has largely followed a one-size-fits-all model—but that paradigm is beginning to break. On this episode of The McKinsey Podcast , Stéphane Bancel, CEO of Moderna, joins Eric Kutcher, McKinsey’s North America chair, to explore how mRNA technology is transforming healthcare. From the rapid development of COVID-19 vaccines to new approaches to rare genetic diseases and individualized cancer treatments, Bancel explains how treating biology as information could reshape how drugs are discovered, manufactured, and delivered. In this recurring series, Eric speaks with top CEOs about the practice of leadership. The McKinsey Podcast is cohosted by Lucia Rahilly and Roberta Fusaro. To watch the full-length version of this interview, visit The McKinsey Podcast  playlist  on McKinsey’s YouTube channel. See www.mckinsey.com/privacy-policy for privacy information

People in this episode

Host: Eric Kutcher

Guest: Stéphane Bancel

Topics covered

• healthcare
• mRNA technology
• COVID-19 vaccines
• genetic diseases
• cancer treatments
• leadership

Keywords

• healthcare
• mRNA
• COVID-19
• vaccines
• genetic diseases
• cancer treatments
• leadership

Mentioned in this episode

Organizations: Moderna, McKinsey & Company, McKinsey

More episodes of The McKinsey Podcast

• The world is changing. Can fashion keep up? · June 11, 2026 · 25 min
• How CEOs can navigate the new era of trade · June 4, 2026 · 27 min
• Move first or fall behind: How AI is rewriting the rules of banking · May 28, 2026 · 24 min
• Sell, close, or continue? The transfer of US businesses is at a crossroads · May 14, 2026 · 26 min

Explore listener stats, chart rankings, contacts and more on the The McKinsey Podcast podcast page.